A disruptor of the $1.5T inflammation market with proven assets, bold IP, and a high-impact leadership team.

Jackie Iversen, Co-Founder & Chief Clinical Officer

Jim Iversen, Co-Founder & CEO

jiversen@sen-jam.com

www.sen-jam.com